121 related articles for article (PubMed ID: 11922198)
41. The use of Amsler grids in early chloroquine retinopathy.
Easterbrook M
Ophthalmology; 1984 Nov; 91(11):1368-72. PubMed ID: 6514305
[TBL] [Abstract][Full Text] [Related]
42. Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.
Cole S; Walsh A; Yin X; Wechalekar MD; Smith MD; Proudman SM; Veale DJ; Fearon U; Pitzalis C; Humby F; Bombardieri M; Axel A; Adams H; Chiu C; Sharp M; Alvarez J; Anderson I; Madakamutil L; Nagpal S; Guo Y
Arthritis Res Ther; 2018 May; 20(1):85. PubMed ID: 29720240
[TBL] [Abstract][Full Text] [Related]
43. More thoughts about antimalarials: should one prescribe chloroquine?
Esdaile JM
J Rheumatol; 1999 Sep; 26(9):1868. PubMed ID: 10493663
[No Abstract] [Full Text] [Related]
44. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
Easterbrook M
J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
[No Abstract] [Full Text] [Related]
45. Evaluation of a follow-up protocol for patients on chloroquine and hydroxychloroquine treatment.
Sanabria MR; Toledo-Lucho SC
Arch Soc Esp Oftalmol; 2016 Jan; 91(1):10-4. PubMed ID: 26627497
[TBL] [Abstract][Full Text] [Related]
46. Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients.
Lin YZ; Li RN; Lin CH; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
Autoimmunity; 2014 Feb; 47(1):23-6. PubMed ID: 24219225
[TBL] [Abstract][Full Text] [Related]
47. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.
Conti F; Ceccarelli F; Perricone C; Alessandri C; Conti V; Massaro L; Truglia S; Spinelli FR; Spadaro A; Valesini G
Rheumatology (Oxford); 2011 Jun; 50(6):1148-52. PubMed ID: 21278072
[TBL] [Abstract][Full Text] [Related]
48. Influence of HumDN1 VNTR polymorphism on DNASE1 expression in systemic lupus erythematosus and rheumatoid arthritis.
AlFadhli S; Ghanem AA
Immunol Invest; 2014; 43(5):411-23. PubMed ID: 24564745
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis.
Lee YH; Kim HJ; Rho YH; Choi SJ; Ji JD; Song GG
Rheumatol Int; 2004 May; 24(3):133-6. PubMed ID: 14872281
[TBL] [Abstract][Full Text] [Related]
50. [Chloroquine maculopathy and prevention of malaria].
Balo KP; Mensah A; Mihluedo H
J Fr Ophtalmol; 1996; 19(12):770-6. PubMed ID: 9033902
[TBL] [Abstract][Full Text] [Related]
51. [Association between lipid profile and Apo E genotype in Spanish children (8-15 years old)].
Bercedo Sanz A; González-Lamuño D; Muñoz Cacho P; Albajar Molera M; Rodríguez Rey JC; Braga Fernández S; Málaga Guerrero S; García Fuentes M
An Esp Pediatr; 1998 Aug; 49(2):120-4. PubMed ID: 9773544
[TBL] [Abstract][Full Text] [Related]
52. Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study.
Porkka KV; Taimela S; Kontula K; Lehtimäki T; Aalto-Setälä K; Akerblom HK; Viikari JS
Clin Genet; 1994 Mar; 45(3):113-21. PubMed ID: 7913004
[TBL] [Abstract][Full Text] [Related]
53. [The therapy of systemic lupus erythematosus].
Ochsendorf FR; Runne U
Dtsch Med Wochenschr; 1997 Jul; 122(27):877. PubMed ID: 9280702
[No Abstract] [Full Text] [Related]
54. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
[TBL] [Abstract][Full Text] [Related]
55. [Chloroquine retinopathy. Peculiar behavior of the light sense].
Stein R; Godel V; Nemet P
Klin Monbl Augenheilkd; 1972 Aug; 161(2):183-91. PubMed ID: 4638561
[No Abstract] [Full Text] [Related]
56. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
Tzekov R
Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
[TBL] [Abstract][Full Text] [Related]
57. [Ocular changes and general condition in lupus erythematosus (SLE)--own observation].
Brydak-Godowska J
Klin Oczna; 2007; 109(1-3):11-4. PubMed ID: 17687904
[TBL] [Abstract][Full Text] [Related]
58. Static perimetry in chloroquine retinopathy. Perifoveal patterns of visual field depression.
Hart WM; Burde RM; Johnston GP; Drews RC
Arch Ophthalmol; 1984 Mar; 102(3):377-80. PubMed ID: 6703984
[TBL] [Abstract][Full Text] [Related]
59. Chloroquine retinopathy in patients with rheumatoid arthritis.
Elman A; Gullberg R; Nilsson E; Rendahl I; Wachtmeister L
Scand J Rheumatol; 1976; 5(3):161-66. PubMed ID: 981992
[TBL] [Abstract][Full Text] [Related]
60. [Retinal toxicity following chloroquine therapy].
Ferreras A; Pinilla I; Abecia E; Pajarín AB; Honrubia FM
Arch Soc Esp Oftalmol; 2007 Feb; 82(2):103-8. PubMed ID: 17323250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
